PyInvesting

Market research

TED.F TerrAscend Corp

F EUR Healthcare

Latest close

0.2815 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
121M
P/E ratio
Not available
Analyst target
Not available
Beta
Not available

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

TerrAscend Corp is currently in a long term uptrend where the price is trading 0.5% above its 200 day moving average.

From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.7.

TerrAscend Corp's total revenue rose by 152.4% to $65M since the same quarter in the previous year.

Its net income has increased by 33.8% to $-112M since the same quarter in the previous year.

Finally, its free cash flow grew by 120.0% to $5M since the same quarter in the previous year.

Based on the above factors, TerrAscend Corp gets an overall score of 5/5.